Company / CapEx per Share
MARAVAI LIFESCIENCES HOLDINGS, INC. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.10
FY2025
5-year range
$0.06 / $0.59
FY2021-FY2025
Trend
-14.2%
vs FY2024
Sector context
#57 of 192
Health Care
What the data says
At $0.10, MARAVAI LIFESCIENCES HOLDINGS, INC.'s capex per share ranks #57 of 192 in the Health Care sector. CapEx per Share has declined for 3 consecutive years, from $0.59 in FY2022 to $0.10 in FY2025.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of -35.3%.
Declined from $0.25 to $0.10 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -44.8%
- 5-Year CAGR
- -35.3%
- 10-Year CAGR
- -
Sector benchmark
#57 of 192 in Health CareTop 30% of 192This company $0.10 Sector average $3.54
▼
-97.2% below sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 14.2% year-over-year.
- Ranks #57 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | -14.2% |
| FY2024 | $0.12 | -54.3% |
| FY2023 | $0.25 | -57.0% |
| FY2022 | $0.59 | +910.9% |
| FY2021 | $0.06 | -93.3% |
| FY2020 | $0.88 | +1201.5% |
| FY2019 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026